Publikationer pr. år
Publikationer pr. år
Publikationer pr. år
* In vivo cancer models based on:
- xenografts of luminescent/fluorescent human cancer cell lines, allowing for the precise follow-up of tumor development and response to therapy (lymphoma, colon, breast)
- Generation of Patient-Derived Xenograft (haematological cancers)
- Spontaneous murine cancer models;
* In vitro cancer models based on:
- cell lines
- flow cytometry
- RNA/protein expression
Mouse models; human haemaological cancers (lymphoma such as DLBCL, MCL and CTCL, or MDS); in vivo imaging; new therapy
To decipher the molecular mechanisms (RNA/epigenetics/metabolism) leading to tumor resistance or relapse during therapy in lymphoma (DLBCL, MCL, CTCL) or MDS.
None
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review